Delayed first contact in a universally insured population: time to care and COVID-19 outcomes in Mexican primary care
- 1Instituto Mexicano del Seguro Social
Abstract
Time from symptom onset to first care may be a modifiable determinant of COVID-19 outcomes, but it is rarely quantified in primary care. This retrospective cohort study included all 5,248 confirmed SARS-CoV-2 cases (RT-PCR or certified rapid antigen test) notified to the national surveillance system (SINOLAVE) by a large family medicine unit of the Mexican Social Security Institute (IMSS) in Leon, Mexico, between April 2020 and April 2021. Pandemic waves were classified using the official IMSS definition. Wave profiles were compared with chi-square tests and Bonferroni correction, and predictors of death were assessed by multivariable logistic regression, with sensitivity analyses adjusting for severity signs at first contact. Of the cases, 53.8% were female, mean age was 41.1 years, and 317 deaths (6.0%) were registered. Median time to first care was 3 days (interquartile range: 2-5). Case fatality was 3.0% among patients presenting within 3 days and 9.1% among those presenting later. Later presentation (> 3 days) was associated with death (adjusted odds ratio = 1.98; 95% confidence interval: 1.47-2.65), but the association was attenuated after adjustment for severity signs at first contact (adjusted odds ratio = 1.20; 95% confidence interval: 0.85-1.69), which were more frequent among later presenters (21.8% vs. 9.3%). From the first to the second wave, fever (76.1% to 56.9%), diabetes (22.8% to 9.6%), and case fatality (10.5% to 4.8%) decreased, whereas anosmia and dysgeusia increased (all p < 0.001). Surveillance data cannot distinguish clinical progression during delay from late presentation of already severe patients. Delay persisted despite universal entitlement to care, indicating that insurance coverage alone did not ensure timely presentation; prospective cohorts measuring severity at onset are needed.
Related
- National Outcomes of Sepsis in Publicly Insured Children: 2021–2023
- Oncological outcomes of direct versus delayed surgery after neoadjuvant short-course radiotherapy for rectal cancer: national cohort study
- Does Timing Matter? Perioperative Outcomes and Quality of Life After Early Versus Delayed Radical Cystectomy Following BCG Therapy
- Receipt of guideline-concordant prenatal care among Medicaid-insured women with disabilities in Texas
- A Narrative Review of Medicare Part D Medication Therapy Management Program Design Challenges and the Development of an Evidence-Informed MTM Benefit Program for a Large Self-Insured Employer.
BibTeX
@misc{vazquez2026delayed,
title = {{Delayed first contact in a universally insured population: time to care and COVID-19 outcomes in Mexican primary care}},
author = {V. J. GODINEZ VAZQUEZ and E. R. Nieves-Ruiz and L. F. Razo Mendoza},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.10.26367735},
url = {https://www.medrxiv.org/content/10.64898/2026.11.10.26367735v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Delayed first contact in a universally insured population: time to care and COVID-19 outcomes in Mexican primary care
AU - V. J. GODINEZ VAZQUEZ
AU - E. R. Nieves-Ruiz
AU - L. F. Razo Mendoza
PY - 2026
DA - 2026/11/10
PB - medRxiv
DO - 10.64898/2026.11.10.26367735
UR - https://www.medrxiv.org/content/10.64898/2026.11.10.26367735v1
AB - Time from symptom onset to first care may be a modifiable determinant of COVID-19 outcomes, but it is rarely quantified in primary care. This retrospective cohort study included all 5,248 confirmed SARS-CoV-2 cases (RT-PCR or certified rapid antigen test) notified to the national surveillance system (SINOLAVE) by a large family medicine unit of the Mexican Social Security Institute (IMSS) in Leon, Mexico, between April 2020 and April 2021. Pandemic waves were classified using the official IMSS definition. Wave profiles were compared with chi-square tests and Bonferroni correction, and predictors of death were assessed by multivariable logistic regression, with sensitivity analyses adjusting for severity signs at first contact. Of the cases, 53.8% were female, mean age was 41.1 years, and 317 deaths (6.0%) were registered. Median time to first care was 3 days (interquartile range: 2-5). Case fatality was 3.0% among patients presenting within 3 days and 9.1% among those presenting later. Later presentation (> 3 days) was associated with death (adjusted odds ratio = 1.98; 95% confidence interval: 1.47-2.65), but the association was attenuated after adjustment for severity signs at first contact (adjusted odds ratio = 1.20; 95% confidence interval: 0.85-1.69), which were more frequent among later presenters (21.8% vs. 9.3%). From the first to the second wave, fever (76.1% to 56.9%), diabetes (22.8% to 9.6%), and case fatality (10.5% to 4.8%) decreased, whereas anosmia and dysgeusia increased (all p < 0.001). Surveillance data cannot distinguish clinical progression during delay from late presentation of already severe patients. Delay persisted despite universal entitlement to care, indicating that insurance coverage alone did not ensure timely presentation; prospective cohorts measuring severity at onset are needed.
ER -